Taiho

News

FDA hands BeOne, Taiho approvals for blood cancers

BeOne gets the nod for BCL2 inhibitor Beqalzi in mantle cell lymphoma, while Taiho's Inqovi has acute myeloid leukaemia added to its label.

News

Taiho's late-stage Duchenne candidate fails trial

Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.

News

Taiho snaps up ADC partner Araris for up to $1.14bn

Taiho has reached a deal to buy Swiss biotech Araris, around 18 months after they started collaborating on antibody-drug conjugates for cancer.

News

Merck & Co joins KRAS gold rush with Taiho and Astex collabo...

US-based Merck & Co has forged an R&D tie-up with Taiho and Astex Pharmaceuticals, focused on developing small molecule drugs targeting the KRAS gene that has become the subject of

FDA hands BeOne, Taiho approvals for blood cancers

Taiho's late-stage Duchenne candidate fails trial

Taiho snaps up ADC partner Araris for up to $1.14bn

Merck & Co joins KRAS gold rush with Taiho and Astex collabo...

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Taiho

Editor's Picks